Epidemiology and risk factors of biliary tract and primary liver tumors

Surgical Oncology Clinics of North America

Volumn 23, Issue 2, 2014, Pages 171-188

  Augustine, Mathew M ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Benign liver tumor; Cholangiocarcinoma; Gallbladder cancer; Hepatocelluar cancer; Viral hepatitis

Indexed keywords

AFLATOXIN; THORIUM DIOXIDE;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANOMALOUS PANCREATICOBILIARY DUCT JUNCTION; BILE DUCT CARCINOMA; BILE DUCT CYST; BILE DUCT STONE; CALCIFICATION; CANCER INCIDENCE; CHOLELITHIASIS; CHOLESTEROL METABOLISM; CHRONIC HEPATITIS; CHRONIC HEPATITIS B; CHRONIC INFLAMMATION; FASCIOLIASIS; GALLBLADDER CANCER; GALLBLADDER POLYP; GEOGRAPHIC DISTRIBUTION; HELICOBACTER BILIS; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; NONALCOHOLIC FATTY LIVER; OBESITY; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; TYPHOID FEVER;

BENIGN LIVER TUMOR; CHOLANGIOCARCINOMA; GALLBLADDER CANCER; HEPATOCELLUAR CANCER; VIRAL HEPATITIS;

BILIARY TRACT NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; RISK FACTORS;

EID: 84896711353     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2013.10.001     Document Type: Review

References (122)

1. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-2576. PubMed PMID: 17570226.
2. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2(9):533-543. PubMed PMID: 11905707.
3. Chang M.H., Chen C.J., Lai M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. NEngl J Med 1997, 336(26):1855-1859. PubMed PMID: 9197213.
4. Chang M.H., You S.L., Chen C.J., et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. JNatl Cancer Inst 2009, 101(19):1348-1355. PubMed PMID: 19759364.
5. Ni Y.H., Chen D.S. Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol 2010, 58(4):296-300. PubMed PMID: 20116181.
6. Yu S.Z. Primary prevention of hepatocellular carcinoma. JGastroenterol Hepatol 1995, 10(6):674-682. PubMed PMID: 8580413.
7. El-Serag H.B. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007, 37(Suppl 2):S88-S94. PubMed PMID: 17877502.
8. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. NEngl J Med 1999, 340(10):745-750. PubMed PMID: 10072408.
9. El-Serag H.B., Lau M., Eschbach K., et al. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 2007, 167(18):1983-1989. PubMed PMID: 17923599.
10. Yu M.W., Chen C.J. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993, 53(4):790-794. PubMed PMID: 8381328.
11. Chen J.G., Zhu J., Parkin D.M., et al. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 2006, 119(6):1447-1454. PubMed PMID: 16596645.
12. Moriya T., Koyama T., Tanaka J., et al. Epidemiology of hepatitis C virus in Japan. Intervirology 1999, 42(2-3):153-158. PubMed PMID: 10516469.
13. Seeff L.B., Hoofnagle J.H. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 2006, 25(27):3771-3777. PubMed PMID: 16799618.
14. Donato F., Tagger A., Gelatti U., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002, 155(4):323-331. PubMed PMID: 11836196.
15. Bressac B., Kew M., Wands J., et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991, 350(6317):429-431. PubMed PMID: 1672732.
16. Stickel F., Hellerbrand C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut 2010, 59(10):1303-1307. PubMed PMID: 20650925.
17. El-Serag H.B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006, 4(3):369-380.
18. Hassan M.M., Curley S.A., Li D., et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 2010, 116(8):1938-1946. PubMed PMID: 20166205.
19. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. NEngl J Med 2003, 348(17):1625-1638. PubMed PMID: 12711737.
20. Moller H., Mellemgaard A., Lindvig K., et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994, 30A(3):344-350. PubMed PMID: 8204357.
21. Wolk A., Gridley G., Svensson M., et al. Aprospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001, 12(1):13-21. PubMed PMID: 11227921.
22. Siegel A.B., Zhu A.X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009, 115(24):5651-5661. PubMed PMID: 19834957. PubMed Central PMCID: PMC3397779.
23. Reddy K.R., Kligerman S., Levi J., et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001, 67(2):173-178. PubMed PMID: 11243545.
24. Mergo P.J., Ros P.R. Benign lesions of the liver. Radiol Clin North Am 1998, 36(2):319-331. PubMed PMID: 9520985.
25. Trotter J.F., Everson G.T. Benign focal lesions of the liver. Clin Liver Dis 2001, 5(1):17-42. v. PubMed PMID: 11218914.
26. Pain J.A., Gimson A.E., Williams R., et al. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 1991, 32(5):524-527. PubMed PMID: 2040476. PubMed Central PMCID: 1378930.
27. Wanless I.R., Mawdsley C., Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985, 5(6):1194-1200. PubMed PMID: 4065824.
28. Luciani A., Kobeiter H., Maison P., et al. Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?. Gut 2002, 50(6):877-880. PubMed PMID: 12010893. PubMed Central PMCID: 1773241.
29. Nguyen B.N., Flejou J.F., Terris B., et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999, 23(12):1441-1454. PubMed PMID: 10584697.
30. Koch N., Gintzburger D., Seelentag W., et al. Rupture of hepatic focal nodular hyperplasia. About two cases. Ann Chir 2006, 131(4):279-282. PubMed PMID: 16443188. Epub 2006/01/31 [in French].
31. Machida T., Hirayama M., Horita S., et al. Telangiectatic focal nodular hyperplasia accompanied with hemorrhage and necrosis during the course: report of a case. Nihon Shokakibyo Gakkai Zasshi 2008, 105(6):847-853. PubMed PMID: 18525192 [in Japanese].
32. Edmondson H.A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. NEngl J Med 1976, 294(9):470-472. PubMed PMID: 173996.
33. Rooks J.B., Ory H.W., Ishak K.G., et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979, 242(7):644-648. PubMed PMID: 221698.
34. Heinemann L.A., Weimann A., Gerken G., et al. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998, 3(4):194-200. PubMed PMID: 10036602.
35. Chang C.Y., Hernandez-Prera J.C., Roayaie S., et al. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013, 2013:604860. PubMed PMID: 23509632. PubMed Central PMCID: PMC3595661.
36. Farges O., Ferreira N., Dokmak S., et al. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011, 60(1):85-89. PubMed PMID: 21148580.
37. Sasaki M., Nakanuma Y. Overview of hepatocellular adenoma in Japan. Int J Hepatol 2012, 2012:648131. PubMed PMID: 22973519. PubMed Central PMCID: PMC3438775.
38. Lazcano-Ponce E.C., Miquel J.F., Munoz N., et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001, 51(6):349-364. PubMed PMID: 11760569.
39. Andia M.E., Hsing A.W., Andreotti G., et al. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer 2008, 123(6):1411-1416. PubMed PMID: 18566990. PubMed Central PMCID: 2864002.
40. Serra I., Calvo A., Csendes A., et al. Gastric and gallbladder carcinoma in Chile: epidemiological changes and control programs. Rev Med Chil 1989, 117(7):834-836. PubMed PMID: 2519441 [in Spanish].
41. Randi G., Franceschi S., La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006, 118(7):1591-1602. PubMed PMID: 16397865.
42. Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev 2003, 12(1):15-24. PubMed PMID: 12548106.
43. Kratzer W., Kron M., Hay B., et al. Prevalence of cholecystolithiasis in South Germany-an ultrasound study of 2,498 persons of a rural population. ZGastroenterol 1999, 37(12):1157-1162. PubMed PMID: 10666839 [in German].
44. Kratzer W., Mason R.A., Kachele V. Prevalence of gallstones in sonographic surveys worldwide. JClin Ultrasound 1999, 27(1):1-7. PubMed PMID: 9888092.
45. Stinton L.M., Shaffer E.A. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012, 6(2):172-187. PubMed PMID: 22570746. PubMed Central PMCID: PMC3343155.
46. Shrikhande S.V., Barreto S.G., Singh S., et al. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause!. Eur J Surg Oncol 2010, 36(6):514-519. PubMed PMID: 20537839.
47. Kimura W., Shimada H., Kuroda A., et al. Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones. Am J Gastroenterol 1989, 84(4):386-390. PubMed PMID: 2929559.
48. Diehl A.K., Beral V. Cholecystectomy and changing mortality from gallbladder cancer. Lancet 1981, 2(8239):187-189. PubMed PMID: 6114251.
49. Polk H.C. Carcinoma and the calcified gall bladder. Gastroenterology 1966, 50(4):582-585. PubMed PMID: 4286335.
50. Stephen A.E., Berger D.L. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 2001, 129(6):699-703. PubMed PMID: 11391368.
51. Cunningham S.C., Alexander H.R. Porcelain gallbladder and cancer: ethnicity explains a discrepant literature?. Am J Med 2007, 120(4):e17-e18. PubMed PMID: 17398213.
52. Kim J.H., Kim W.H., Yoo B.M., et al. Should we perform surgical management in all patients with suspected porcelain gallbladder?. Hepatogastroenterology 2009, 56(93):943-945. PubMed PMID: 19760916.
53. Towfigh S., McFadden D.W., Cortina G.R., et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg 2001, 67(1):7-10. PubMed PMID: 11206901.
54. Lewis J.T., Talwalkar J.A., Rosen C.B., et al. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol 2007, 31(6):907-913. PubMed PMID: 17527079.
55. Said K., Glaumann H., Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. JHepatol 2008, 48(4):598-605. PubMed PMID: 18222013.
56. Kratzer W., Haenle M.M., Voegtle A., et al. Ultrasonographically detected gallbladder polyps: a reason for concern? A seven-year follow-up study. BMC Gastroenterol 2008, 8:41. PubMed PMID: 18793401. PubMed Central PMCID: PMC2553794.
57. Kumar S., Kumar S., Kumar S. Infection as a risk factor for gallbladder cancer. JSurg Oncol 2006, 93(8):633-639. PubMed PMID: 16724347.
58. Caygill C.P., Hill M.J., Braddick M., et al. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 1994, 343(8889):83-84. PubMed PMID: 7903779.
59. Dutta U., Garg P.K., Kumar R., et al. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000, 95(3):784-787. PubMed PMID: 10710075.
60. Matsukura N., Yokomuro S., Yamada S., et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002, 93(7):842-847. PubMed PMID: 12149151.
61. Pandey M., Mishra R.R., Dixit R., et al. Helicobacter bilis in human gallbladder cancer: results of a case-control study and a meta-analysis. Asian Pac J Cancer Prev 2010, 11(2):343-347. PubMed PMID: 20843113.
62. Elnemr A., Ohta T., Kayahara M., et al. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. Hepatogastroenterology 2001, 48(38):382-386. PubMed PMID: 11379314.
63. Keswani R.N., Mahvi D.M. Education and imaging. Hepatobiliary and pancreatic: anomalous pancreaticobiliary junction and gallbladder cancer. JGastroenterol Hepatol 2012, 27(10):1644. PubMed PMID: 22994436.
64. Hu B., Gong B., Zhou D.Y. Association of anomalous pancreaticobiliary ductal junction with gallbladder carcinoma in Chinese patients: an ERCP study. Gastrointest Endosc 2003, 57(4):541-545. PubMed PMID: 12665766.
65. Myers R.P., Shaffer E.A., Beck P.L. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol 2002, 16(3):187-194. PubMed PMID: 11930198.
66. Chen C.Y., Lu C.L., Chang F.Y., et al. Risk factors for gallbladder polyps in the Chinese population. Am J Gastroenterol 1997, 92(11):2066-2068. PubMed PMID: 9362194.
67. Segawa K., Arisawa T., Niwa Y., et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am J Gastroenterol 1992, 87(5):630-633. PubMed PMID: 1595653.
68. Lin W.R., Lin D.Y., Tai D.I., et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. JGastroenterol Hepatol 2008, 23(6):965-969. PubMed PMID: 17725602.
69. Jorgensen T., Jensen K.H. Polyps in the gallbladder. A prevalence study. Scand J Gastroenterol 1990, 25(3):281-286. PubMed PMID: 2320947.
70. Konstantinidis I.T., Bajpai S., Kambadakone A.R., et al. Gallbladder lesions identified on ultrasound. Lessons from the last 10 years. JGastrointest Surg 2012, 16(3):549-553. PubMed PMID: 22108768.
71. Larsson S.C., Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 2007, 96(9):1457-1461. PubMed PMID: 17375043. PubMed Central PMCID: PMC2360167.
72. Pandey S.N., Dixit M., Choudhuri G., et al. Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility. Int J Gastrointest Cancer 2006, 37(4):124-128. PubMed PMID: 17987404.
73. Xu H.L., Cheng J.R., Andreotti G., et al. Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Carcinogenesis 2011, 32(1):58-62. PubMed PMID: 21062971.
74. Gatto M., Bragazzi M.C., Semeraro R., et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 2010, 42(4):253-260. PubMed PMID: 20097142.
75. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006, 3(1):33-42. PubMed PMID: 16397610.
76. Shaib Y., El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004, 24(2):115-125. PubMed PMID: 15192785.
77. Greenlee R.T., Hill-Harmon M.B., Murray T., et al. Cancer statistics, 2001. CA Cancer J Clin 2001, 51(1):15-36. PubMed PMID: 11577478.
78. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249. PubMed PMID: 19474385.
79. Khan S.A., Taylor-Robinson S.D., Toledano M.B., et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. JHepatol 2002, 37(6):806-813. PubMed PMID: 12445422.
80. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002, 2:10. PubMed PMID: 11991810. PubMed Central PMCID: 113759.
81. Taylor-Robinson S.D., Toledano M.B., Arora S., et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001, 48(6):816-820. PubMed PMID: 11358902. PubMed Central PMCID: 1728314.
82. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001, 33(6):1353-1357. PubMed PMID: 11391522.
83. Khan S.A., Emadossadaty S., Ladep N.G., et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?. JHepatol 2012, 56(4):848-854. PubMed PMID: 22173164.
84. Welzel T.M., McGlynn K.A., Hsing A.W., et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. JNatl Cancer Inst 2006, 98(12):873-875. PubMed PMID: 16788161.
85. Angulo P., Lindor K.D. Primary sclerosing cholangitis. Hepatology 1999, 30(1):325-332. PubMed PMID: 10385674.
86. Chapman R.W. The management of primary sclerosing cholangitis. Curr Gastroenterol Rep 2003, 5(1):9-17. PubMed PMID: 12530943.
87. Bambha K., Kim W.R., Talwalkar J., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125(5):1364-1369. PubMed PMID: 14598252.
88. Boonstra K., Beuers U., Ponsioen C.Y. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. JHepatol 2012, 56(5):1181-1188. PubMed PMID: 22245904.
89. Lindkvist B., Benito de Valle M., Gullberg B., et al. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010, 52(2):571-577. PubMed PMID: 20683956.
90. de Valle M.B., Bjornsson E., Lindkvist B. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int 2012, 32(3):441-448. PubMed PMID: 22098097.
91. Bergquist A., Ekbom A., Olsson R., et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. JHepatol 2002, 36(3):321-327. PubMed PMID: 11867174.
92. Burak K., Angulo P., Pasha T.M., et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004, 99(3):523-526. PubMed PMID: 15056096.
93. Bouvard V., Baan R., Straif K., et al. Areview of human carcinogens-Part B: biological agents. Lancet Oncol 2009, 10(4):321-322. PubMed PMID: 19350698.
94. Lim M.K., Ju Y.H., Franceschi S., et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 2006, 75(1):93-96. PubMed PMID: 16837714.
95. Sriamporn S., Pisani P., Pipitgool V., et al. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, northeast Thailand. Trop Med Int Health 2004, 9(5):588-594. PubMed PMID: 15117303.
96. Choi D., Lim J.H., Lee K.T., et al. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. JHepatol 2006, 44(6):1066-1073. PubMed PMID: 16480786.
97. Honjo S., Srivatanakul P., Sriplung H., et al. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer 2005, 117(5):854-860. PubMed PMID: 15957169.
98. Shin H.R., Lee C.U., Park H.J., et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996, 25(5):933-940. PubMed PMID: 8921477.
99. Parkin D.M., Srivatanakul P., Khlat M., et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991, 48(3):323-328. PubMed PMID: 1645697.
100. Shin H.R., Oh J.K., Masuyer E., et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010, 101(3):579-585. PubMed PMID: 20085587.
101. Wu W., Qian X., Huang Y., et al. Areview of the control of clonorchiasis sinensis and Taenia solium taeniasis/cysticercosis in China. Parasitol Res 2012, 111(5):1879-1884. PubMed PMID: 23052782.
102. Torbenson M., Yeh M.M., Abraham S.C. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol 2007, 31(9):1410-1413. PubMed PMID: 17721197.
103. Shaib Y.H., El-Serag H.B., Nooka A.K., et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007, 102(5):1016-1021. PubMed PMID: 17324130.
104. Wu Z.F., Yang N., Li D.Y., et al. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. JViral Hepat 2013, 20(5):306-310. PubMed PMID: 23565611.
105. Zhang L., Cai J.Q., Zhao J.J., et al. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. JSurg Oncol 2010, 101(3):233-238. PubMed PMID: 20169539.
106. Zhou H.B., Wang H., Li Y.Q., et al. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011, 17(10):1292-1303. PubMed PMID: 21455328. PubMed Central PMCID: PMC3068264.
107. Chijiiwa K., Koga A. Surgical management and long-term follow-up of patients with choledochal cysts. Am J Surg 1993, 165(2):238-242. PubMed PMID: 8427404.
108. Hewitt P.M., Krige J.E., Bornman P.C., et al. Choledochal cysts in adults. Br J Surg 1995, 82(3):382-385. PubMed PMID: 7796017.
109. Ishibashi T., Kasahara K., Yasuda Y., et al. Malignant change in the biliary tract after excision of choledochal cyst. Br J Surg 1997, 84(12):1687-1691. PubMed PMID: 9448616.
110. Lipsett P.A., Pitt H.A., Colombani P.M., et al. Choledochal cyst disease. A changing pattern of presentation. Ann Surg 1994, 220(5):644-652. PubMed PMID: 7979612. PubMed Central PMCID: 1234452.
111. Liu C.L., Fan S.T., Lo C.M., et al. Choledochal cysts in adults. Arch Surg 2002, 137(4):465-468. PubMed PMID: 11926955.
112. Stain S.C., Guthrie C.R., Yellin A.E., et al. Choledochal cyst in the adult. Ann Surg 1995, 222(2):128-133. PubMed PMID: 7639580. PubMed Central PMCID: 1234770.
113. Tashiro S., Imaizumi T., Ohkawa H., et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. JHepatobiliary Pancreat Surg 2003, 10(5):345-351. PubMed PMID: 14598134.
114. Voyles C.R., Smadja C., Shands W.C., et al. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg 1983, 118(8):986-988. PubMed PMID: 6870530.
115. Soreide K., Korner H., Havnen J., et al. Bile duct cysts in adults. Br J Surg 2004, 91(12):1538-1548. PubMed PMID: 15549778.
116. Cheung K.L., Lai E.C. The management of intrahepatic stones. Adv Surg 1996, 29:111-129. PubMed PMID: 8719998.
117. Tsui W.M., Chan Y.K., Wong C.T., et al. Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features. Semin Liver Dis 2011, 31(1):33-48. PubMed PMID: 21344349.
118. Huang M.H., Chen C.H., Yen C.M., et al. Relation of hepatolithiasis to helminthic infestation. JGastroenterol Hepatol 2005, 20(1):141-146. PubMed PMID: 15610459.
119. Deniz K., Torun E., Celikbilek M., et al. Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: report of a case. Surg Today 2011, 41(4):591-595. PubMed PMID: 21431501.
120. Liu Z.Y., Zhou Y.M., Shi L.H., et al. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary Pancreat Dis Int 2011, 10(6):626-631. PubMed PMID: 22146627.
121. Balamurali G., du Plessis D.G., Wengoy M., et al. Thorotrast-induced primary cerebral angiosarcoma: case report. Neurosurgery 2009, 65(1):E210-E211. [discussion: E1]. PubMed PMID: 19574803.
122. Kato I., Kido C. Increased risk of death in thorotrast-exposed patients during the late follow-up period. Jpn J Cancer Res 1987, 78(11):1187-1192. PubMed PMID: 2826375.